104 related articles for article (PubMed ID: 7762279)
1. Vaccine-related determinants of the interleukin-2 response to influenza vaccination in healthy young and elderly adults.
McElhaney JE; Meneilly GS; Pinkoski MJ; Lechelt KE; Bleackley RC
Vaccine; 1995 Jan; 13(1):6-10. PubMed ID: 7762279
[TBL] [Abstract][Full Text] [Related]
2. Split-virus influenza vaccines: do they provide adequate immunity in the elderly?
McElhaney JE; Meneilly GS; Lechelt KE; Bleackley RC
J Gerontol; 1994 Mar; 49(2):M37-43. PubMed ID: 8126350
[TBL] [Abstract][Full Text] [Related]
3. Responses to influenza vaccination in different T-cell subsets: a comparison of healthy young and older adults.
McElhaney JE; Upshaw CM; Hooton JW; Lechelt KE; Meneilly GS
Vaccine; 1998 Nov; 16(18):1742-7. PubMed ID: 9778750
[TBL] [Abstract][Full Text] [Related]
4. Antibody response to whole-virus and split-virus influenza vaccines in successful ageing.
McElhaney JE; Meneilly GS; Lechelt KE; Beattie BL; Bleackley RC
Vaccine; 1993; 11(10):1055-60. PubMed ID: 8212827
[TBL] [Abstract][Full Text] [Related]
5. The effect of influenza vaccination on IL2 production in healthy elderly: implications for current vaccination practices.
McElhaney JE; Meneilly GS; Beattie BL; Helgason CD; Lee SF; Devine RD; Bleackley RC
J Gerontol; 1992 Jan; 47(1):M3-8. PubMed ID: 1730850
[TBL] [Abstract][Full Text] [Related]
6. Helper and cytotoxic T lymphocyte responses to influenza vaccination in healthy compared to diabetic elderly.
McElhaney JE; Pinkoski MJ; Au D; Lechelt KE; Bleackley RC; Meneilly GS
Vaccine; 1996 Apr; 14(6):539-44. PubMed ID: 8782353
[TBL] [Abstract][Full Text] [Related]
7. Age-related decline in interleukin 2 production in response to influenza vaccine.
McElhaney JE; Beattie BL; Devine R; Grynoch R; Toth EL; Bleackley RC
J Am Geriatr Soc; 1990 Jun; 38(6):652-8. PubMed ID: 2358627
[TBL] [Abstract][Full Text] [Related]
8. Cytokine production after influenza vaccination in a healthy elderly population.
Bernstein ED; Gardner EM; Abrutyn E; Gross P; Murasko DM
Vaccine; 1998 Nov; 16(18):1722-31. PubMed ID: 9778748
[TBL] [Abstract][Full Text] [Related]
9. Comparison of humoral immune responses to trivalent influenza split vaccine in young, middle-aged and elderly people.
Glathe H; Bigl S; Grosche A
Vaccine; 1993; 11(7):702-5. PubMed ID: 8342318
[TBL] [Abstract][Full Text] [Related]
10. Effect of age on cytotoxic T lymphocyte memory as well as serum and local antibody responses elicited by inactivated influenza virus vaccine.
Powers DC; Belshe RB
J Infect Dis; 1993 Mar; 167(3):584-92. PubMed ID: 8440930
[TBL] [Abstract][Full Text] [Related]
11. The antigenicity of whole virus versus subunit trivalent influenza vaccines -- a field trial in the Israel Defence Forces, 1978.
Kark JD; Lebiush M; Rannon L; Witztum E; Nili E; Kedem R
Med Microbiol Immunol; 1981; 170(1):55-62. PubMed ID: 7029236
[TBL] [Abstract][Full Text] [Related]
12. Key Determinants of Cell-Mediated Immune Responses: A Randomized Trial of High Dose Vs. Standard Dose Split-Virus Influenza Vaccine in Older Adults.
McElhaney JE; Verschoor CP; Haynes L; Pawelec G; Loeb M; Andrew MK; Kuchel GA
Front Aging; 2021 May; 2():. PubMed ID: 35128529
[TBL] [Abstract][Full Text] [Related]
13. Immune response to influenza vaccination in institutionalized elderly: effect on different T-cell subsets.
McElhaney JE; Gravenstein S; Upshaw CM; Hooton JW; Krause P; Drinka P
Vaccine; 1998 Feb; 16(4):403-9. PubMed ID: 9607063
[TBL] [Abstract][Full Text] [Related]
14. In vivo T cell activation, in vitro defective IL-2 secretion, and response to influenza vaccination in elderly women.
Huang YP; Pechere JC; Michel M; Gauthey L; Loreto M; Curran JA; Michel JP
J Immunol; 1992 Feb; 148(3):715-22. PubMed ID: 1730868
[TBL] [Abstract][Full Text] [Related]
15. Cellular immune responses of older adults to four influenza vaccines: Results of a randomized, controlled comparison.
Kumar A; McElhaney JE; Walrond L; Cyr TD; Merani S; Kollmann TR; Halperin SA; Scheifele DW
Hum Vaccin Immunother; 2017 Sep; 13(9):2048-2057. PubMed ID: 28635557
[TBL] [Abstract][Full Text] [Related]
16. The effect of whole virus influenza vaccination on theophylline pharmacokinetics.
Hannan SE; May JJ; Pratt DS; Richtsmeier WJ; Bertino JS
Am Rev Respir Dis; 1988 Apr; 137(4):903-6. PubMed ID: 2451459
[TBL] [Abstract][Full Text] [Related]
17. Augmentation of the immune response to influenza vaccine by acetylsalicylic acid: a clinical trial in a geriatric population.
Hsia J; Tang T; Parrott M; Rogalla K
Methods Find Exp Clin Pharmacol; 1994 Nov; 16(9):677-83. PubMed ID: 7746030
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of trivalent subunit and split influenza vaccines (1989-90 winter season) in volunteers of different groups of age.
Zei T; Neri M; Iorio AM
Vaccine; 1991 Sep; 9(9):613-7. PubMed ID: 1950094
[TBL] [Abstract][Full Text] [Related]
19. Induction of IL-2 and IFN-gamma in BALB/c mice immunised with subunit influenza A vaccine in combination with whole cell or acellular DTP vaccine.
Tamizifar H; Jennings R; Ali SA; Potter CW
J Med Microbiol; 1997 Jan; 46(1):61-6. PubMed ID: 9003747
[TBL] [Abstract][Full Text] [Related]
20. Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon-gamma production and local IgA response.
Tomoda T; Morita H; Kurashige T; Maassab HF
Vaccine; 1995 Feb; 13(2):185-90. PubMed ID: 7625114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
